mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

Rufaida Farheen

Author Profile
1
Publications
1
Years Active
1
Collaborators
6
Citations

Publications by Rufaida Farheen

1 publication found • Active 2016-2016

2016

1 publication

Wnt/β-Catenin As Anticancer Drug Target

with Iffath Rizwana
8/1/2016

Wnt /β-catenin signaling plays an important role in tumor cell dedifferentiation and proliferation. Wnt proteins are a family of secreted glycoproteins. Abnormal activation of wnt signaling results in tumor progression. Wnt proteins binds to the frizzled receptors and LRP5/6 co-receptors and through the stabilization of β-catenin a critical mediator, initiates a complex signaling cascade that plays an important role in regulating cell proliferation and differentiations. The elevated levels of oncogenic protein-β-catenin have been observed in many of the human cancers, indicating that this pathway plays an important role in tumor development. The wnt signaling can be inhibited at the extracellular level, at regulatory protein level and also by targeting the expressions of β-catenin by protein knockdown and by targeting the downstream mediators of β-catenin signaling such as c-myc, cyclin D1, PPARS and COX-2. In this review we discuss the effects of  NSAIDS and flavanoids that are being used or explored to target the β-catenin signaling in the treatment of cancers.

Author Statistics
Total Publications:1
Years Active:1
First Publication:2016
Latest Publication:2016
Collaborators:1
Citations:6
Collaborators
Whatsapp